Yeah that was outlined on P14 of the update.
There are other companies using autologous CAR-T cell therapies to attack tumour cells but “apparently” exosome treatments have potential advantages over these.
Exciting stuff.
I missed the DW webinar ( was on the 15th hole)
Im sure there will be link in the coming days to watch / listen to it but can anyone please post a dot point summary.
Thanks in advance
Yeah that was outlined on P14 of the update. There are other...
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
51.0¢ |
Change
0.010(2.00%) |
Mkt cap ! $46.93M | |||
| Open | High | Low | Value | Volume |
| 50.0¢ | 51.0¢ | 50.0¢ | $10.46K | 20.54K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 5424 | 50.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 51.0¢ | 3083 | 1 |
View Market Depth
| Last trade - 15.45pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
50.5¢ |
Change
0.010 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 50.0¢ | 51.0¢ | 50.0¢ | 5305 | ||
| Last updated 15.59pm 17/05/2024 ? | |||||
| IIQ (ASX) Chart |